nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Advances and perspectives of dendritic cell-based active immunotherapies in follicular lymphoma
|
Cox, Maria Christina |
|
|
69 |
6 |
p. 913-925 |
artikel |
2 |
Anti-inflammatory microenvironment of esophageal adenocarcinomas negatively impacts survival
|
Karstens, Karl-Frederick |
|
|
69 |
6 |
p. 1043-1056 |
artikel |
3 |
Cancer bio-immunotherapy XVI annual NIBIT-(Italian Network for Tumor Biotherapy) meeting, October 11–13 2018, Milan, Italy
|
Bellone, Matteo |
|
|
69 |
6 |
p. 1141-1151 |
artikel |
4 |
CD1d expression and invariant natural killer T-cell numbers are reduced in patients with upper gastrointestinal cancers and are further impaired by commonly used chemotherapies
|
Melo, Ashanty M. |
|
|
69 |
6 |
p. 969-982 |
artikel |
5 |
Clinical relevance of the comparative expression of immune checkpoint markers with the clinicopathological findings in patients with primary and chemoreduced retinoblastoma
|
Singh, Lata |
|
|
69 |
6 |
p. 1087-1099 |
artikel |
6 |
Correction to: Predictive value of positron emission tomography for the prognosis of immune checkpoint inhibitors (ICIs) in malignant tumors
|
Wu, Qing |
|
|
69 |
6 |
p. 937 |
artikel |
7 |
Critical role of PD-L1 expression on non-tumor cells rather than on tumor cells for effective anti-PD-L1 immunotherapy in a transplantable mouse hematopoietic tumor model
|
Rodriguez-Barbosa, Jose-Ignacio |
|
|
69 |
6 |
p. 1001-1014 |
artikel |
8 |
Development and characterization of a novel anti-OX40 antibody for potent immune activation
|
Kuang, Zhihui |
|
|
69 |
6 |
p. 939-950 |
artikel |
9 |
ESTIMATE algorithm is not appropriate for inferring tumor purity and stromal and immune cell admixture in hematopoietic or stromal tumors
|
Liu, Qiang |
|
|
69 |
6 |
p. 1153-1154 |
artikel |
10 |
Identification and validation of tumour microenvironment-based immune molecular subgroups for gastric cancer: immunotherapeutic implications
|
Zhou, Yu-Jie |
|
|
69 |
6 |
p. 1057-1069 |
artikel |
11 |
Inhibition of IDO leads to IL-6-dependent systemic inflammation in mice when combined with photodynamic therapy
|
Wachowska, Malgorzata |
|
|
69 |
6 |
p. 1101-1112 |
artikel |
12 |
Intratumoral injection of hemagglutinating virus of Japan-envelope vector yielded an antitumor effect for advanced melanoma: a phase I/IIa clinical study
|
Kiyohara, Eiji |
|
|
69 |
6 |
p. 1131-1140 |
artikel |
13 |
miRNA-5119 regulates immune checkpoints in dendritic cells to enhance breast cancer immunotherapy
|
Zhang, Meng |
|
|
69 |
6 |
p. 951-967 |
artikel |
14 |
Myeloid-derived suppressor cells impede T cell functionality and promote Th17 differentiation in oral squamous cell carcinoma
|
Dar, Asif A. |
|
|
69 |
6 |
p. 1071-1086 |
artikel |
15 |
Neutrophils are mediators of metastatic prostate cancer progression in bone
|
Costanzo-Garvey, Diane L. |
|
|
69 |
6 |
p. 1113-1130 |
artikel |
16 |
Nivolumab in patients with metastatic renal cell carcinoma and chronic hepatitis C virus infection
|
Tsimafeyeu, Ilya |
|
|
69 |
6 |
p. 983-988 |
artikel |
17 |
Oncolytic Newcastle disease virus activation of the innate immune response and priming of antitumor adaptive responses in vitro
|
Burke, Shannon |
|
|
69 |
6 |
p. 1015-1027 |
artikel |
18 |
Phosphorylated vimentin as an immunotherapeutic target against metastatic colorectal cancer
|
Ohara, Mizuho |
|
|
69 |
6 |
p. 989-999 |
artikel |
19 |
Predictive value of positron emission tomography for the prognosis of immune checkpoint inhibitors (ICIs) in malignant tumors
|
Wu, Qing |
|
|
69 |
6 |
p. 927-936 |
artikel |
20 |
Prostaglandin E2 in a TLR3- and 7/8-agonist-based DC maturation cocktail generates mature, cytokine-producing, migratory DCs but impairs antigen cross-presentation to CD8+ T cells
|
Gierlich, Philipp |
|
|
69 |
6 |
p. 1029-1042 |
artikel |
21 |
Seeking and destroying the evils from the inside-translating cancer immunity to fight COVID-19
|
Dong, Haidong |
|
|
69 |
6 |
p. 911-912 |
artikel |